Please use this identifier to cite or link to this item: https://hdl.handle.net/10316/95895
Title: Re-Use of Caco-2 Monolayers in Permeability Assays—Validation Regarding Cell Monolayer Integrity
Authors: Pires, Cristiana L.
Praça, Catarina 
Martins, Patrícia A. T.
Batista de Carvalho, Ana L. M. 
Ferreira, Lino 
Catarro, Maria Paula M. Marques 
Moreno, Maria João 
Keywords: Caco-2 cells; High-throughput; Intestinal permeability; Lucifer yellow; Tight junctions
Issue Date: 2021
Publisher: MDPI
Project: UIDB/00070/2020 
NEUROATLANTIC/EAPA_791/2018 
0624_2IQBIONEURO_6_E 
SFRH/BD/138873/2018 
UIDB/00313/2020 
UIDP/00313/2020 
PT2020-PTDC/QUI-OUT/29373/2017 
PT2020-PTDC/DTP-FTO/2784/2014 
Serial title, monograph or event: Pharmaceutics
Volume: 13
Issue: 10
Abstract: Caco-2 monolayers are a common in vitro model used to evaluate human intestinal absorption. The reference protocol requires 21 days post-seeding to establish a stable and confluent cell monolayer, which is used in a single permeability assay during the period of monolayer stability (up to day 30). In this work, we characterize variations in the tightness of the cell monolayer over the stable time interval and evaluate the conditions required for their re-use in permeability assays. The monolayer integrity was assessed through TEER measurements and permeability of the paracellular marker Lucifer Yellow (LY), complemented with nuclei and ZO-1 staining for morphological studies and the presence of tight junctions. Over 150 permeability assays were performed, which showed that manipulation of the cell monolayer in the permeability assay may contribute significantly to the flux of LY, leading to Papp values that are dependent on the sampling duration. The assay also leads to a small decrease in the cell monolayer TEER, which is fully recovered when cell monolayers are incubated with culture media for two full days. When this procedure is followed, the cell monolayers may be used for permeability assays on days 22, 25, and 28, triplicating the throughput of this important assay. © 2021 by the authors. Licensee MDPI, Basel, Switzerland.
URI: https://hdl.handle.net/10316/95895
ISSN: 1999-4923
DOI: 10.3390/pharmaceutics13101563
Rights: openAccess
Appears in Collections:I&D CQC - Artigos em Revistas Internacionais
I&D CNC - Artigos em Revistas Internacionais
I&D QFM-UC - Artigos em Revistas Internacionais
FMUC Medicina - Artigos em Revistas Internacionais
FCTUC Ciências da Vida - Artigos em Revistas Internacionais

Files in This Item:
File Description SizeFormat
pharmaceutics-13-01563-v2.pdf4.4 MBAdobe PDFView/Open
Show full item record

SCOPUSTM   
Citations

16
checked on Mar 18, 2024

WEB OF SCIENCETM
Citations

16
checked on Feb 2, 2024

Page view(s)

268
checked on Mar 26, 2024

Download(s)

194
checked on Mar 26, 2024

Google ScholarTM

Check

Altmetric

Altmetric


This item is licensed under a Creative Commons License Creative Commons